Emergent BioSolutions
EBS
$6.25
Share price
-5.30%
Change (1 day)
1.30%
Change (1 year)
Categories
Earnings for Emergent BioSolutions (EBS)
Earnings in 2025 (TTM): -$0.9 Million USD
According to Emergent BioSolutions 's latest financial reports the company's current earnings are $0.93 Billion USD. In 2024 the company made an earning of -$71.9 Million USD, an increase over its 2023 earnings that were of -$0.65 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Emergent BioSolutions from 2004 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -$0.9 Million | -98.75% |
| 2024 | -$71.9 Million | -88.82% |
| 2023 | -$0.65 Billion | 242.73% |
| 2022 | -$0.19 Billion | -153.8% |
| 2021 | $0.34 B | -20.43% |
| 2020 | $0.43 B | 278.02% |
| 2019 | $0.11 B | 27.11% |
| 2018 | $91.25 M | -27.12% |
| 2017 | $0.12 B | 17.21% |
| 2016 | $0.10 B | 0.45% |
| 2015 | $0.10 B | 73.51% |
| 2014 | $61.3 M | 41.36% |
| 2013 | $43.36 M | 35.2% |
| 2012 | $32.07 M | 0.4% |
| 2011 | $31.94 M | -56.46% |
| 2010 | $73.37 M | 76.73% |
| 2009 | $41.51 M | 32.94% |
| 2008 | $31.23 M | -5.62% |
| 2007 | $33.09 M | |
| 2005 | $47.91 M | 269.89% |
| 2004 | $12.95 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | $21.45 B | -2,383,433.33% | 🇺🇸 USA |
 SIGA Technologies SIGA | $56.45 M | -6,372.50% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.41 B | -601,334.44% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | -$0.22 Billion | 24,034.33% | 🇺🇸 USA |
 Pfizer PFE | $10.34 B | -1,149,100.00% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.45 B | -50,544.44% | 🇮🇱 Israel |
 Soligenix SNGX | -$10.67 Million | 1,085.13% | 🇺🇸 USA |